Krystal Biotech
Rachael Borromeo, MS, RAC, serves as the Sr. Director of Regulatory CMC & Operations at Krystal Biotech, Inc., having progressed through roles including Director and Associate Director of Regulatory Affairs since October 2018. Prior to joining Krystal Biotech, Rachael held the position of Associate Director of Regulatory Affairs at Noveome Biotherapeutics, Inc. from September 2009 to October 2018. Earlier professional experience includes regulatory affairs coordination at Allegheny Health Network and quality control supervision at Wyeth, now part of Pfizer, Inc. Rachael's career began as a Research Associate at The Harvard Gene Therapy Initiative and as a Stability Coordinator at Bracco Research USA. Rachael holds a Master's degree in Regulatory Affairs and Quality Assurance from Temple University Graduate School and a Bachelor of Science in Molecular Biology from Allegheny College.
This person is not in the org chart
Krystal Biotech
6 followers
Krystal Biotech, Inc. is using gene therapy to develop effective and novel treatments for skin diseases.